In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...